TickerFactsScreenerDevelopers

MYRIAD GENETICS INC (MYGN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: $84.04M2010: $155.09M2011: $130.83M2012: $141.80M2013: $173.87M2016: $166.30M2017: $106.20M2018: $115.90M2019: $83.70M2020: $60.70M2021: $18.60M2022: -$106.30M2023: -$110.90M2024: -$8.70M2025: $1.80M$1.80M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$1.80M+120.7%
2024-$8.70M+92.2%
2023-$110.90M-4.3%
2022-$106.30M-671.5%
2021$18.60M-69.4%
2020$60.70M-27.5%
2019$83.70M-27.8%
2018$115.90M+9.1%
2017$106.20M-36.1%
2016$166.30M—
2013$173.87M+22.6%
2012$141.80M+8.4%
2011$130.83M-15.6%
2010$155.09M+84.5%
2009$84.04M—